674
Views
3
CrossRef citations to date
0
Altmetric
Clinical Study

Pseudoexfoliation syndrome in chronic kidney disease patients

, &
Pages 456-458 | Received 19 Sep 2014, Accepted 09 Dec 2014, Published online: 14 Jan 2015

References

  • Cumurcu T, Kilic R, Yologlu S. The frequency of pseudoexfoliation syndrome in the middle Black Sea region of Turkey. Eur J Ophthalmol. 2010;20(6):1007–1011
  • Forsius H. Prevalence of pseudoexfoliation of the lens in Finns, Lapps, Icelanders, Eskimos and Russians. Trans Ophthalmol Soc UK. 1979;99:296–298
  • Aasved H. Prevalence of fibrillopathia epitheliocapsularis [pseudoexfoliation] and capsular glaucoma. Trans Ophthalmol Soc UK. 1979;99:293–295
  • Repo LP, Terasvirta ME, Koivisto KJ. Generalized transluminance of the iris and the frequency of the pseudoexfoliation syndrome in the eyes of transient ischemic attack patients. Ophthalmology. 1993;100:352–355
  • Scholotzer-Schrehardtz UM, Koca MR, Naumann GOH, Volkhol H. Pseudoexfoliation syndrome; ocular manifestation of a systemic disorder? Arch Ophthalmol. 1992;110:1752–1756
  • Streeten BW, Li ZY, Wallace RN, Eagle RC, Keshgegian AA. Pseudoexfoliation fibrillopathy in visceral organs of a patient withpseudoexfoliation syndrome. Arch Ophthalmol. 1992;110:1757–1762
  • Ritch R, Schlotzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45:265–315
  • Naji M, Naji F, Suran D, Gracner T, Kanic V, Pahor D. Systemic endothelial dysfunction in patients with pseudoexfoliation syndrome. Klin Monbl Augenheilkd. 2008;225(11):963–967
  • Helbig H, Schlötzer-Schrehardt U, Noske W, Kellner U, Foerster MH, Naumann GO. Anterior-chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome. Ger J Ophthalmol. 1994;3(3):148–153
  • Atalar PT, Atalar E, Kilic H, et al. Impaired systemic endothelial function in patients with pseudoexfoliation syndrome. Int Heart J. 2006;47(1):77–84
  • Ishikawa M, Namiki A, Kubota T, et al. Effect of hyperhomocysteinemia on endothelial activation and dysfunction in patients with end-stage renal disease. Am J Cardiol. 2001;88:1203–1205
  • Kunz K, Petitjean P, Lisri M, et al. Cardiovascular morbidity and endothelial dysfunction in chronic hemodialysis patients: ishomocyst(e)ine the missing link? Nephrol Dial Transplant. 1999;14:1934–1942
  • Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. Modification of Diet in Renal Disease Study Group. A more accurate method toestimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med. 1999;130:461–470
  • Zenkel M, Lewczuk P, Jünemann A, Kruse FE, Naumann GO, Schlötzer-Schrehardt U. Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma. Am J Pathol. 2010;176(6):2868–2879
  • Mastalerz-Migas A, Reksa D, Porarski M. Comparıson of a statin vs. hypolipemic diet on the oxidant status in hemodialyzed patients with chronic renal failure. J Physiol Pharmacol. 2007;58(5):363–370
  • Zakrzewski PA, Mackenzie PJ, Tsai G, Warner SJ, Levin A, Mikelberg FS. Does an association exist between pseudoexfoliation syndrome and chronic kidney disease? J Glaucoma. 2012; 21(8):562–566
  • Psilas KG, Stefaniotou MJ, Aspiotis MB. Pseudoexfoliation syndrome and diabetes mellitus. Acta Ophthalmol (Copenh). 1991;69(5):664–666
  • Sollosy M. Incidence of the uveal pseudoexfoliation syndrome in patients with diabetes mellitus. Oftalmologia. 2004;48(1):76–80

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.